Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, FL, USA.
Division of Health Care Delivery Research, Mayo Clinic Florida, Jacksonville, FL, USA.
Anaesthesiol Intensive Ther. 2022;54(2):108-113. doi: 10.5114/ait.2022.117548.
Aortic stenosis (AS) is a cardiac valvular lesion that can cause sudden death. Spinal anesthesia (SA) has been considered a relative contraindication in patients with AS. We sought to compare outcomes in patients with AS undergoing SA versus general anesthesia (GA) for lower extremity total joint arthroplasty (TJA).
A retrospective chart review was conducted of elective, primary TJA cases between January 1, 2011, and November 30, 2017, at three tertiary care academic medical centers. Participants included 89 patients with AS undergoing TJA with SA, and 74 with AS undergoing TJA with GA. Primary endpoints included 90-day mortality, blood transfusion, hospital length of stay (LOS), and the 90-day incidence of deep vein thrombosis, pulmonary embolism, myocardial infarction, and stroke. Propensity score matching was utilized to assess differences in outcomes between patients receiving GA vs. SA.
After matching, there were no significant differences in mortality (GA 0% vs. SA 1%; OR: 1.01 [0.98, 1.05]; P = 0.498), serious complications GA 2.2% vs. SA 0%; OR: 1.00 [0.95, 1.05]; P = 0.233), blood transfusion (GA 12.4% vs. 9% SA; OR: 1.01 [0.86, 1.19]; P = 0.751) within 90 days in the GA vs. SA groups, nor hospital LOS (GA mean 3.0 vs. SA mean 2.9, 0.3 [-0.11, 0.70]; P = 0.153).
There were no differences in the incidence of mortality or serious complications in matched patients with AS undergoing elective primary lower extremity TJA under SA versus GA.
主动脉瓣狭窄(AS)是一种心脏瓣膜病变,可导致猝死。椎管内麻醉(SA)被认为是 AS 患者的相对禁忌证。我们旨在比较 AS 患者接受 SA 与全身麻醉(GA)行下肢全关节置换术(TJA)的结局。
对 2011 年 1 月 1 日至 2017 年 11 月 30 日在三家三级护理学术医疗中心行择期初次 TJA 的患者进行回顾性图表审查。参与者包括 89 例接受 SA 行 TJA 的 AS 患者和 74 例接受 GA 行 TJA 的 AS 患者。主要终点包括 90 天死亡率、输血、住院时间(LOS)和 90 天深静脉血栓形成、肺栓塞、心肌梗死和中风的发生率。采用倾向评分匹配评估接受 GA 与 SA 的患者之间结局的差异。
匹配后,GA 组死亡率(0% vs. SA 组 1%;OR:1.01 [0.98,1.05];P = 0.498)、严重并发症(GA 组 2.2% vs. SA 组 0%;OR:1.00 [0.95,1.05];P = 0.233)、90 天内输血(GA 组 12.4% vs. SA 组 9%;OR:1.01 [0.86,1.19];P = 0.751)差异均无统计学意义,两组间 LOS 也无差异(GA 组均值 3.0 天 vs. SA 组均值 2.9 天,β 0.3[-0.11,0.70];P = 0.153)。
在接受 SA 或 GA 行择期初次下肢 TJA 的匹配 AS 患者中,死亡率或严重并发症的发生率无差异。